New blood test predicts risk of heart attack and stroke with twice previous accuracy A powerful blood panel Read the full article here
Phase 3, randomized, placebo-controlled clinical trial of CAN-2409+prodrug in combination with standard of care external beam radiation (EBRT) for newly diagnosed localized prostate cancer Read the full article here john doe 5 July 3, 2025
Clonal hematopoiesis (CH) in participants with metastatic castration-resistant prostate cancer (mCRPC) receiving 177Lu-PSMA-617 or cabazitaxel: An exploratory post-hoc analysis of a randomized phase II trial (TheraP; ANZUP 1603) Read the full article here john doe 5 July 3, 2025
Zanzalintinib (zanza) + nivolumab (nivo) ± relatlimab (rela) in patients (pts) with previously untreated clear cell renal cell carcinoma (ccRCC): Results from an expansion cohort of the phase 1b STELLAR-002 study Read the full article here john doe 5 July 3, 2025
Combination casdatifan plus cabozantinib expansion cohort of phase 1 ARC-20 study in previously treated patients with clear cell renal cell carcinoma Read the full article here john doe 5 July 3, 2025
Circulating tumor DNA (ctDNA) in patients with muscle-invasive bladder cancer (MIBC) who received perioperative durvalumab (D) in NIAGARA Read the full article here john doe 5 July 3, 2025
Episode 8: ASCO 2025 Debrief: Key Updates in Genitourinary Cancer Management Read the full article here john doe 5 July 3, 2025
Looking for a natural way to lower blood pressure? Whole grains might be the answer Read the full article here john doe 5 July 3, 2025
Association of ‘weekend warrior’ physical activity pattern and erectile dysfunction: A large cross-sectional study in Brazil Read the full article here john doe 5 July 3, 2025
Immune and metabolic effects of African heritage diets versus Western diets in men: a randomized controlled trial Read the full article here john doe 5 July 3, 2025